Abstract
Background/Aims:Cholelithiasis is a common disorder in north-eastern Germany. Analyses of risk factors for gallstone formation in this population may have high explanatory power. Gender-specific risk factors for gallstone formation and their interactions were investigated by using data of the population-based Study of Health in Pomerania (SHIP). Methods:Data of 4,202 persons aged 20–79 years were available. Cholelithiasis was defined by either a prior history of cholecystectomy or the presence of gallstones on abdominal ultrasound. Multivariable analyses were performed to identify independent risk factors for gallstone formation. Results:There were 468 persons (11.1%) with previous cholecystectomy and 423 persons (10.1%) with sonographic evidence of gallstones. Women had a twofold higher risk for cholelithiasis compared to men. Age, body mass index and low serum HDL cholesterol levels were independently associated with cholelithiasis in both men and women. In the male population, low alcohol and high coffee consumption and in the female population, low physical activity, were further independently related to gallstone formation. Additionally, sex-specific interactions between risk factors were found. Conclusions: Female sex, age and being overweight are major risk factors for gallstone formation in this region where cholelithiasis is a frequent disorder. Additional factors and interactions contribute to a gender-specific gallstone risk.
Journal Section:
Original Paper
References
1.
Kratzer W, Mason RA, Kachele V: Prevalence of gallstones in sonographic surveys worldwide. J Clin Ultrasound 1999;27:1–7.
[PubMed]
2.
Singh V, Trikha B, Nain C, Singh K, Bose S: Epidemiology of gallstone disease in Chandigarh: A community-based study. J Gastroenterol Hepatol 2001;16:560–563.
[PubMed]
3.
Borch K, Jonsson KA, Zdolsek JM, Halldestam I, Kullman E: Prevalence of gallstone disease in a Swedish population sample. Relations to occupation, childbirth, health status, life style, medications, and blood lipids. Scand J Gastroenterol 1998;33:1219–1225.
[PubMed]
4.
Chapman BA, Burt MJ, Frampton CM, Collett JA, Yeo KH, Wilkinson ID, Cook HB, Barclay MJ, Ross AG, George PM: The prevalence of viral hepatitis (HAV, HBV and HCV) in the Christchurch community. NZ Med J 2000;113:394–396.
[PubMed]
5.
Caroli-Bosc FX, Le Gall P, Pugliese P, Delabre B, Caroli-Bosc C, Demarquay JF, Delmont JP, Rampal P, Montet JC: General Practitioners’ Group of Vidauban. Role of fibrates and HMG-CoA reductase inhibitors in gallstone formation: Epidemiological study in an unselected population. Dig Dis Sci 2001;46:540–544.
[PubMed]
6.
Loria P, Dilengite MA, Bozzoli M, Carubbi F, Messora R, Sassatelli R, Bertolotti M, Tampieri A, Tartoni PL, Cassinadri M, Della Ciana M, Contemori M, Save N, Sordi B, Alimenti G, Fabrizi F, Buciuni A, Carulli N: Prevalence rates of gallstone disease in Italy. The Chianciano population study. Eur J Epidemiol 1994;10:143–150.
[PubMed]
7.
Martinez de Pancorbo C, Carballo F, Horcajo P, Aldeguer M, de la Villa I, Nieto E, Gaspar MJ, de la Morena J: Prevalence and associated factors for gallstone disease: Results of a population survey in Spain. J Clin Epidemiol 1997;50:1347–1355.
[PubMed]
8.
Acalovschi M, Blendea D, Feier C, Letia AI, Ratiu N, Dumitrascu DL, Veres A: Risk factors for symptomatic gallstones in patients with liver cirrhosis: A case-control study. Am J Gastroenterol 2003;98:1856–1860.
[PubMed]
9.
La Vecchia C, Decarli A, Ferraroni M, Negri E: Alcohol drinking and prevalence of self-reported gallstone disease in the 1983 Italian National Health Survey. Epidemiology 1994;5:533–536.
[PubMed]
10.
Kono S, Eguchi H, Honjo S, Todoroki I, Oda T, Shinchi K, Ogawa S, Nakagawa K: Cigarette smoking, alcohol use, and gallstone risk in Japanese men. Digestion 2002;65:177–183.
[PubMed]
11.
Timmer A, Ahrens W, Stegmaier C, Baumgardt-Elms C, Stang A, Jahn I, Jöckel KH: Risk factors and surgery rates in gallstones. Results of a population-based study (in German). Med Klin (Munich) 2000;95:672–677.
[PubMed]
12.
Ishizuka H, Eguchi H, Oda T, Ogawa S, Nakagawa K, Honjo S, Kono S: Relation of coffee, green tea, and caffeine intake to gallstone disease in middle-aged Japanese men. Eur J Epidemiol 2003;18:401–405.
[PubMed]
13.
Leitzmann MF, Stampfer MJ, Willett WC, Spiegelman D, Colditz GA, Giovannucci EL: Coffee intake is associated with lower risk of symptomatic gallstone disease in women. Gastroenterology 2002;123:1823–1830.
[PubMed]
14.
Misciagna G, Leoci C, Guerra V, Chiloiro M, Elba S, Petruzzi J, Mossa A, Noviello MR, Coviello A, Minutolo MC, Mangini V, Messa C, Cavallini A, De Michele G, Giorgio I: Epidemiology of cholelithiasis in southern Italy. II. Risk factors. Eur J Gastroenterol Hepatol 1996;8:585–593.
[PubMed]
15.
Berndt H, Nürnberg D, Pannwitz H: Prevalence of cholelithiasis. Results of an epidemiologic study using sonography in East Germany (in German). Z Gastroenterol 1989;27:662–666.
[PubMed]
16.
John U, Greiner B, Hensel E, Lüdemann J, Piek M, Sauer S, Adam C, Born G, Alte D, Greiser E, Haertel U, Hense H-W, Haerting J, Willich S, Kessler C: Study of Health in Pomerania (SHIP): A health examination survey in an east German region: objectives and design. Soz Präventivmed 2001;46:186–194.
17.
Sherbourne CD, Stewart AL: The MOS social support survey. Soc Sci Med 1991;32:705–714.
[PubMed]
18.
Berkman LF, Syme SL: Social networks, host resistance, and mortality: A nine-year follow-up study of Alameda county residents. Am J Epidemiol 1979;109:186–204.
[PubMed]
19.
Bühringer G, Augustin R, Bergmann E, Bloomfield K, Funk W, Junge B, Kraus L, Merfert-Diete C, Rumpf HJ, Simon R, Töppich J: Alcolhol consumption and alcohol related disorders in Germany (in German). Das Bundesministerium für Gesundheit. Baden-Baden, Nomos, 2000, vol 128.
20.
Winkler G, Döring A: Kurzmethoden zur Charakterisierung des Ernährungsmusters: Einsatz und Auswertung eines Food-Frequency-Fragebogens. Ernährungs Umschau 1995;42:289–291.
21.
Statistisches Landesamt Mecklenburg-Vorpommern 31.12.1999.
22.
Kleinbaum DG, Kupper LL, Morgenstern H: Epidemiologic Research. Principles and Quantitative Methods. New York, Van Nostrand Reinhold/International Thomson Publ Inc, 1982, pp 447–456.
23.
Everhart JE, Yeh F, Lee ET, Hill MC, Fabsitz R, Howard BV, Welty TK: Prevalence of gallbladder disease in American Indian populations: Findings from the Strong Heart Study. Hepatology 2002;35:1507–1512.
[PubMed]
24.
Glambek I, Kvaale G, Arnesjö B, Soreide O: Prevalence of gallstones in a Norwegian population. Scand J Gastroenterol 1987;22:1089–1094.
[PubMed]
25.
Nakeeb A, Comuzzie AG, Martin L, Sonnenberg GE, Swartz-Basile D, Kissebah AH, Pitt HA: Gallstones: Genetics versus environment. Ann Surg 2002;235:842–849.
[PubMed]
26.
Attili AF, Carulli N, Roda E, Barbara B, Capocaccia L, Menotti A, Okoliksanyi L, Ricci G, Capocaccia R, Festi D, et al: Epidemiology of gallstone disease in Italy: Prevalence data of the Multicenter Italian Study on Cholelithiasis (MICOL). Am J Epidemiol 1995;141:158–165.
[PubMed]
27.
Buchner AM, Sonnenberg A: Factors influencing the prevalence of gallstones in liver disease: The beneficial and harmful influences of alcohol. Am J Gastroenterol 2002;97:905–909.
[PubMed]
28.
Kratzer W, Kron M, Hay B, Pfeiffer MM, Kachele V: Prevalence of cholecystolithiasis in South Germany – An ultrasound study of 2,498 persons of a rural population (in German). Z Gastroenterol 1999;37:1157–1162.
[PubMed]
29.
Angelico F, Del Ben M, Barbato A, Conti R, Urbinati G: Ten-year incidence and natural history of gallstone disease in a rural population of women in central Italy. The Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO). Ital J Gastroenterol Hepatol 1997;29:249–254.
[PubMed]
30.
Misciagna G, Centonze S, Leoci C, Guerra V, Cisternino AM, Ceo R, Trevisan M: Diet, physical activity, and gallstones – A population-based, case-control study in southern Italy. Am J Clin Nutr 1999;69:120–126.
[PubMed]
31.
Torgerson JS, Lindroos AK Naslund I, Peltonen M: Gallstones, gallbladder disease, and pancreatitis: Cross-sectional and 2-year data from the Swedish Obese Subjects (SOS) and SOS reference studies. Am J Gastroenterol 2003;98:1032–1041.
[PubMed]
32.
Spathis A, Heaton KW, Emmett PM, Norboo T, Hunt L: Gallstones in a community free of obesity but prone to slow intestinal transit. Eur J Gastroenterol Hepatol 1997;9:201–206.
[PubMed]
33.
Chuang CZ, Martin LF, LeGardeur BY, Lopez A: Physical activity, biliary lipids, and gallstones in obese subjects. Am J Gastroenterol 2001;96:1860–1865.
[PubMed]
34.
Thijs C, Knipschild P, Brombacher P: Serum lipids and gallstones: A case-control study. Gastroenterology 1990;99:843–849.
[PubMed]
35.
Jorgensen T: Gallstones and plasma lipids in a Danish population. Scand J Gastroenterol 1989;24:916–922.
[PubMed]
36.
Chapman BA, Wilson IR, Frampton CM, Chisholm RJ, Stewart NR, Eagar GM, Allan RB: Prevalence of gallbladder disease in diabetes mellitus. Dig Dis Sci 1996;41:2222–2228.
[PubMed]
37.
Basso L, McCollum PT, Darling MR, Tocchi A, Tanner WA: A descriptive study of pregnant women with gallstones. Relation to dietary and social habits, education, physical activity, height, and weight. Eur J Epidemiol 1992;8:629–633.
[PubMed]
© 2005 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2005
You do not currently have access to this content.
